| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |